Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.44 USD
+0.01 (0.27%)
Updated Apr 26, 2024 03:37 PM ET
After-Market: $2.45 +0.01 (0.55%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -1.20 |
EPS Last Quarter | -1.19 |
Last EPS Surprise | -35.23% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.57 |
Next Year | -4.54 |
EPS (TTM) | -4.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.20 | -0.77 | -3.57 | -4.54 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.20 | -0.77 | -3.57 | -4.54 |
High Estimate | -1.20 | -0.77 | -3.57 | -4.54 |
Low Estimate | -1.20 | -0.77 | -3.57 | -4.54 |
Year ago EPS | -1.31 | -1.12 | -4.61 | -3.57 |
Year over Year Growth Est. | 8.40% | 31.25% | 22.56% | -27.17% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.20 | -0.77 | -3.57 | -4.54 |
7 Days Ago | -1.20 | -0.77 | -3.57 | -4.54 |
30 Days Ago | -1.20 | -0.77 | -3.57 | -4.54 |
60 Days Ago | -1.20 | -0.77 | -3.57 | -4.54 |
90 Days Ago | -1.01 | -0.77 | -3.46 | -4.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.20 | -0.77 | -3.57 | -4.54 |
Zacks Consensus Estimate | -1.20 | -0.77 | -3.57 | -4.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.19 | -1.03 | -1.12 | -1.31 | NA |
Estimate | -0.88 | -0.77 | -0.44 | -1.63 | NA |
Difference | -0.31 | -0.26 | -0.68 | 0.32 | -0.23 |
Surprise | -35.23% | -33.77% | -154.55% | 19.63% | -50.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more